Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Vellanki Avanish Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 4 Vellanki Avanish (Chairman and CEO) has filed a Form 4 on Rain Oncology Inc.
Txns: Granted 266,500 options to buy @ $1.21, valued at $322.5k
Granted 133,250 options to buy @ $1.21, valued at $161.2k
06/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/15/2022 4 Vellanki Avanish (Chairman and CEO) has filed a Form 4 on Rain Therapeutics Inc.
Txns: Gifted 59,618 shares @ $0
Gifted 59,618 shares @ $0
03/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2022 4 Vellanki Avanish (President and CEO) has filed a Form 4 on Rain Therapeutics Inc.
Txns: Granted 182,300 options to buy @ $8.02, valued at $1.5M
04/29/2021 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
04/27/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/22/2021 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy